LLM JD - Spectrum Pharmaceuticals Chief VP
Insider
LLM JD is Chief VP of Spectrum Pharmaceuticals
| Age | 47 |
| Phone | 617 586 3900 |
| Web | https://www.sppirx.com |
Spectrum Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3821) % which means that it has lost $0.3821 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6502) %, meaning that it created substantial loss on money invested by shareholders. Spectrum Pharmaceuticals' management efficiency ratios could be used to measure how well Spectrum Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Spectrum Pharmaceuticals currently holds 29.43 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Spectrum Pharmaceuticals has a current ratio of 1.75, which is within standard range for the sector. Note, when we think about Spectrum Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 3 records | INSIDER Age | ||
| Abhishek Srivastava | Alaunos Therapeutics | N/A | |
| Kevin Sr | Alaunos Therapeutics | 50 | |
| Drew Deniger | Alaunos Therapeutics | 44 | |
Management Performance
| Return On Equity | -1.65 | |||
| Return On Asset | -0.38 |
Spectrum Pharmaceuticals Leadership Team
Elected by the shareholders, the Spectrum Pharmaceuticals' board of directors comprises two types of representatives: Spectrum Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spectrum. The board's role is to monitor Spectrum Pharmaceuticals' management team and ensure that shareholders' interests are well served. Spectrum Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spectrum Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, VP Devel | ||
| Michael Grabow, Exec Officer | ||
| Bimal Shah, VP Devel | ||
| Nora Brennan, Ex Officer | ||
| Thomas Riga, CEO Pres | ||
| LLM JD, Chief VP | ||
| MD FRCPC, Ex Officer |
Spectrum Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Spectrum Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.65 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.52) % | |||
| Operating Margin | (2.47) % | |||
| Current Valuation | 185.27 M | |||
| Shares Outstanding | 205.25 M | |||
| Shares Owned By Insiders | 11.00 % | |||
| Shares Owned By Institutions | 22.93 % | |||
| Number Of Shares Shorted | 3.33 M | |||
| Price To Earning | (19.44) X |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |